ARRAY BIOPHARMA INC's ticker is and the CUSIP is 04269XAB1. A total of 13 filers reported holding ARRAY BIOPHARMA INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $50,155,000 | +50.7% | 16,500,000 | -13.2% | 1.42% | +45.7% |
| Q1 2019 | $33,290,000 | +45.7% | 19,000,000 | 0.0% | 0.97% | +6.0% |
| Q4 2018 | $22,845,000 | -3.7% | 19,000,000 | 0.0% | 0.92% | +25.9% |
| Q3 2018 | $23,717,000 | -7.1% | 19,000,000 | 0.0% | 0.73% | -15.8% |
| Q2 2018 | $25,524,000 | +1.3% | 19,000,000 | 0.0% | 0.87% | -10.9% |
| Q1 2018 | $25,196,000 | +16.8% | 19,000,000 | 0.0% | 0.97% | +3.7% |
| Q4 2017 | $21,578,000 | – | 19,000,000 | – | 0.94% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bluefin Trading, LLC | 426,050 | $129,484,000 | 18.33% |
| CSS LLC/IL | 20,740,000 | $63,098,000 | 3.63% |
| Weiss Asset Management LP | 10,225,000 | $31,105,000 | 1.89% |
| Redmile Group, LLC | 16,500,000 | $50,155,000 | 1.42% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 7,600,000 | $23,136,000 | 0.17% |
| LAZARD ASSET MANAGEMENT LLC | 10,690,000 | $32,542,000 | 0.05% |
| SG Americas Securities, LLC | 9,000 | $2,740,000 | 0.02% |
| DEUTSCHE BANK AG\ | 3,000,000 | $9,117,000 | 0.01% |
| Jefferies Group LLC | 230,000 | $699,000 | 0.01% |
| Citadel Advisors | 3,000,000 | $9,129,000 | 0.00% |